In addition, previous studies have indicated that the impact of JunD in metabolic cardiomyopathy and NAFLD is mainly caused by promoting intracellular lipid deposition through the PPARγ signaling pathway. Here, JUND is linked to metabolic dysfunction-associated steatotic liver disease.